Colivet SF 500 500000 IU/ml Oplossing voor injectie
Colivet SF 500 500000 IU/ml Oplossing voor injectie
Authorised
- COLISTIN SULFATE
Product identification
Medicine name:
Colivet SF 500 500000 IU/ml Oplossing voor injectie
Colivet SF 500 500000 IU/ml Solution injectable
Colivet SF 500 500000 IU/ml Injektionslösung
Active substance:
- COLISTIN SULFATE
Target species:
-
Pig
-
Cattle (calf)
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
COLISTIN SULFATE500000.00/international unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Meat and offal21day21 days after the end of the treatment
-
-
Cattle (calf)
-
Meat and offal26day26 days after the end of the treatment
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01XB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Colivet SF 500 100 ml Vial Solution for injection
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Prodivet Pharmaceuticals
Marketing authorisation date:
Manufacturing sites for batch release:
- Prodivet Pharmaceuticals
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V496577
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.